CD82 and neoplasm: For monitoring differential in vitro tumor biological effects of KAI1-WT vs. KAI1-SP, human breast cancer cell lines MDA-MB 231 and MDA-MB-435, respectively, were stably transfected to overexpress either of the two KAI1 variants [28, 29].